Aesthetics at Edition
Sculptra
Not a filler. A rebuilder. Results that emerge the way youth departed — gradually.
Not a filler. A rebuilder. Results that emerge the way youth departed — gradually.
Sculptra is not a traditional filler. Its active ingredient — poly-L-lactic acid — is a biocompatible synthetic that works by stimulating your body's own collagen production over a series of treatments. There is no immediate volume correction. Instead, results emerge gradually over three to six months and can last two years or more.
This gradual onset is both Sculptra's most important characteristic and the primary reason it is appropriate for certain patients and not others. For those seeking the most natural possible result — one that colleagues and friends cannot identify as a treatment — Sculptra's slow progression is an advantage. For those seeking immediate correction, it is not the right choice.
At Edition, Dr. Schwartz uses Sculptra primarily for global facial volume restoration in patients with significant volume loss across multiple areas — a situation where discrete filler injections would require unrealistic quantities of product and produce a less natural result than Sculptra's diffuse collagen stimulation.
Sculptra results emerge gradually over 3 to 6 months as collagen builds. Most patients require 2 to 3 treatment sessions spaced 4 to 6 weeks apart. Patience is essential — and rewarded.
Results from a Sculptra treatment series can last 2 years or more — significantly longer than most hyaluronic acid fillers. The collagen produced is your own and behaves naturally with facial movement.
Sculptra Aesthetic is manufactured by Galderma and is FDA-approved for the correction of shallow to deep facial wrinkles and folds in immunocompetent patients. It is supplied as a lyophilized powder that is reconstituted with sterile water before injection — a preparation process that requires precision and affects the final result.
The reconstitution volume and injection technique are critical determinants of outcome. Proper dilution, thorough massage after injection, and appropriate patient selection distinguish excellent Sculptra results from the nodules and irregularities that occur with improper technique.
Sculptra works best for broad areas of volume loss where diffuse collagen stimulation produces a more natural result than multiple discrete filler injections.
Temple volume loss is one of the earliest and most overlooked signs of facial aging. Sculptra restores this volume gradually and naturally — improving the overall shape of the upper face without the telltale fullness of traditional fillers in this area.
For patients with significant midface volume loss across a broad area, Sculptra's diffuse collagen stimulation produces a more natural result than the quantities of HA filler that would otherwise be required.
Sculptra improves skin quality and mild laxity along the jawline and lower face, complementing structural correction from other fillers or surgical intervention.
Beyond volume, Sculptra improves the quality of the overlying skin — increasing thickness, firmness, and the appearance of fine lines through broad collagen stimulation.
Sculptra is increasingly used off-label for body applications including buttock enhancement (the non-surgical BBL), knee laxity, and décolletage rejuvenation. Dr. Schwartz will discuss appropriate candidacy at your consultation.
Sculptra is best suited for patients in their 40s to 60s with global facial volume loss, patients seeking the most natural-looking long-term result, and patients who prefer gradual improvement over immediate correction.
Most patients require 2 to 3 treatment sessions spaced 4 to 6 weeks apart. The number of vials used per session and the total number of sessions depends on the degree of volume loss and the areas being treated. Dr. Schwartz will provide a specific treatment plan at your consultation.
Initial results begin to appear at 4 to 6 weeks after the first treatment as collagen production begins. The full result emerges gradually over 3 to 6 months. Many patients notice that friends and family comment on how rested or refreshed they look without being able to identify a specific change — which is precisely the goal.
Clinical studies demonstrate results lasting 25 months or more. Individual longevity varies based on age, skin quality, lifestyle, and the number of treatment sessions completed. Many patients choose to maintain results with a single touch-up vial annually after completing their initial series.
The most significant risk with Sculptra is the formation of subcutaneous nodules — small bumps under the skin that can occur with improper dilution, injection technique, or insufficient post-treatment massage. In experienced hands with proper technique, this risk is significantly reduced. Dr. Schwartz will review all risks at your consultation.
Yes. Sculptra is frequently combined with hyaluronic acid fillers — Sculptra provides broad, gradual volume restoration while HA fillers address specific areas requiring immediate precision correction. Neuromodulators can be used concurrently. Sequencing with energy-based treatments should be discussed at your consultation.
No. Sculptra stimulates your own collagen and cannot be dissolved. Results fade gradually as collagen naturally turns over — typically over 2 or more years. The gradual nature of both onset and resolution means that Sculptra does not produce the sudden changes that make filler reversal necessary.
A Sculptra consultation at Edition includes a thorough assessment of your facial volume loss, a discussion of realistic expectations and timeline, and a complete treatment plan before any commitment is made. There is no obligation.